HomeCompareLANC vs JNJ

LANC vs JNJ: Dividend Comparison 2026

LANC yields 2.17% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LANC wins by $22.4K in total portfolio value
10 years
LANC
LANC
● Live price
2.17%
Share price
$172.77
Annual div
$3.75
5Y div CAGR
36.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52.7K
Annual income
$10,584.95
Full LANC calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — LANC vs JNJ

📍 LANC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLANCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LANC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LANC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LANC
Annual income on $10K today (after 15% tax)
$184.49/yr
After 10yr DRIP, annual income (after tax)
$8,997.21/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, LANC beats the other by $5,011.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LANC + JNJ for your $10,000?

LANC: 50%JNJ: 50%
100% JNJ50/50100% LANC
Portfolio after 10yr
$41.5K
Annual income
$7,637.17/yr
Blended yield
18.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LANC
Analyst Ratings
1
Buy
7
Hold
1
Sell
Consensus: Hold
Price Target
$216.00
+25.0% upside vs current
Range: $200.00 — $232.00
Altman Z
13.7
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LANC buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLANCJNJ
Forward yield2.17%2.13%
Annual dividend / share$3.75$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR36.7%28%
Portfolio after 10y$52.7K$30.3K
Annual income after 10y$10,584.95$4,689.40
Total dividends collected$29.0K$15.4K
Payment frequencyquarterlyquarterly
SectorConsumer StaplesHealthcare
Analyst consensusHoldBuy
Analyst price target$216.00$228.73

Year-by-year: LANC vs JNJ ($10,000, DRIP)

YearLANC PortfolioLANC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,997$296.71$10,592$272.30+$405.00LANC
2$12,183$416.85$11,289$357.73+$894.00LANC
3$13,626$590.02$12,123$472.89+$1.5KLANC
4$15,423$843.06$13,141$629.86+$2.3KLANC
5$17,722$1,219.11$14,408$846.81+$3.3KLANC
6$20,752$1,789.63$16,021$1,151.60+$4.7KLANC
7$24,882$2,677.31$18,122$1,588.22+$6.8KLANC
8$30,725$4,101.17$20,930$2,228.20+$9.8KLANC
9$39,345$6,469.91$24,792$3,191.91+$14.6KLANC
10$52,685$10,584.95$30,274$4,689.40+$22.4KLANC

LANC vs JNJ: Complete Analysis 2026

LANCConsumer Staples

Lancaster Colony Corporation manufactures and markets food products for the retail and foodservice markets in the United States. The company operates in two segments, Retail and Foodservice. It offers frozen garlic bread under the New York BRAND Bakery; frozen Parkerhouse style yeast and dinner rolls under the Sister Schubert's brand; salad dressings under the Marzetti, Cardini's, and Girard's; flatbread wraps and pizza crusts under the Flatout brand; croutons and salad toppings under the New York BRAND Bakery, Chatham Village, and Marzetti; frozen pasta under the Marzetti Frozen Pasta brand; and vegetable and fruit dips under the Marzetti brand. In addition, it manufactures and sells other products to brand license agreements, including Olive Garden dressings, Buffalo Wild Wings sauces and Chick-fil-A sauces. The company sells its products through sales personnel, food brokers, and distributors to retailers and restaurants. Lancaster Colony Corporation was incorporated in 1961 and is based in Westerville, Ohio.

Full LANC Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this LANC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LANC vs SCHDLANC vs JEPILANC vs OLANC vs KOLANC vs MAINLANC vs ABBVLANC vs MRKLANC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.